a therapeutic gain in solid-tumouir radiotherapy, their toxic effects, either alone or in combination with radiation, have to be expressed selectively in the host's tumour but not in normal tissues. It is already clear that these drugs can radiosensitize and possibly be toxic to solid tumours in the laboratory and the clinic, but what is not clear is whether these effects are expressed selectivelv in the tumour tissues. Under appropriate experimental conditions, it has been possible to demonstrate radiosensitization of the murine skin (Brown, 1975; Yuhas et al., 1977) and testis (Suzuki et al., 1977) after injection of misonidazole (Ro-07-0582, MIS). One couild argue logically that these observations would not limit the clinical application of MIS because the tissues involved are seldom radiation-dose limiting, and the demonstration of radiosensitization required single large doses of radiation which are far beyond those used clinically. These data do suggest, however, that normal tissues contain an as yet unknown fraction of hypoxic cells, or that the action of this drug is more complicated than is realized at present.
W1hatever the basis of these observations, we can no longer assume that normal tissues will be totally unresponsive to the toxic and radiosensitizing actions of MIS under all conditions. This conclusion is unsettling, especially when one considers two facts: systems which are sensitive to the toxic effects of MIS are also 11* Accepted 14 Mlarch 1979 susceptible to its radiosensitizing activity, and clinical studies with MIS have shown a significant incidence of drug-induced peripheral neuropathies (Disch et al., 1978) . These facts, taken together, suggested to us that MIS might radiosensitize neural tissue in general, and the spinal cord in particular.
To test this possibility we chose the X-ray-induced spinal-cord-paralysis system in the Fischer 344 rat. In performing these studies, however, an acute reaction was detected which is summarized in the prable. No acute mortality (death within 10 days) was observed when the rats were given 750 mg/kg of MIIS or when they were given 1400-3000 rad of X-rays to a 16mm segment of the lumbar spinal cord. Wheni an injection of 750 mg/kg of the drug was followed 45 min later by the localized radiation, a statistically significant increase in the number of deaths occurring within 24 h was found (Table ) . Administration of the treatments in the reverse order produced no mortality, suggesting either that the interaction resulted from radiosensitization or that the drug, wlhen administered after exposure, did not reach the irradiated cord in time to generate the toxicity.
Although interesting, this acuite mortality is difficult to relate to the clinical situation, and we wished to determine whether MIS would alter the resistance of rats to late spinal-cord injury, i.e., paralysis. To avoid the acuite toxicity, the drug dose was reduced to 200 mg/kg Figure. I P'<0-001 relative to X-rays only; P<0-025 relative to drug only.
§ P < 0 05 relative to X-rays only, (irtig only, an(d (I1tg after X-rays.
which, as shown in the Table, produces no acute deaths, and 45 min after injection the rats were given graded doses of localized X-rays as above. The Figure summarizes the results of this pilot study through 9-5 months from exposure, and shows that MIS sensitized the rats to radiation-induced spinal-cord paralysis. The radiation doses required to p)roduce paralysis in 50%' of the irradiated rats (Finney, 1962) (Yuhas and Storer, 1969) no protection was apparent (Fig.) . Two points need to be considered in these studies: whether the anaesthetic used (see legend to Fig.) Although these data are limited, they do indicate that radiosensitization of the spinal cord, and possibly other neural elements, needs to be considered in using MIS in combination with radiotherapy.
We report these data at this preliminary stage as a precautionary note, since the use of MIS in clinical radiotherapy is continually expanding (Disch et al., 1978) . Further experiments are at present in progress to determine whether this radiosensitization persists under conditions comparable to those in the clinic.
